Zhou Huiling, Han Mingzhu, Nan Miaomiao, Leng Yingrong, Huang Weiming, Ye Shengtao, Kong Lingyi, Xu Wenjun, Zhang Hao. Isodons A−H, seco-abietane and abietane-type diterpenoids from Isodon lophanthoides: isolation, structural elucidation, and anti-cholestatic activity[J]. Chinese Journal of Natural Medicines, 2025, 23(9): 1133-1142. DOI: 10.1016/S1875-5364(25)60977-0
Citation: Zhou Huiling, Han Mingzhu, Nan Miaomiao, Leng Yingrong, Huang Weiming, Ye Shengtao, Kong Lingyi, Xu Wenjun, Zhang Hao. Isodons A−H, seco-abietane and abietane-type diterpenoids from Isodon lophanthoides: isolation, structural elucidation, and anti-cholestatic activity[J]. Chinese Journal of Natural Medicines, 2025, 23(9): 1133-1142. DOI: 10.1016/S1875-5364(25)60977-0

Isodons A−H, seco-abietane and abietane-type diterpenoids from Isodon lophanthoides: isolation, structural elucidation, and anti-cholestatic activity

  • Eight new diterpenoids, Isodons A−H (18), comprising seco-abietane and abietane-type structures, together with 13 known analogues (921), were isolated from Isodon lophanthoides (Buch.-Ham. ex D. Don) Hara. The compounds (+)-3/(−)-3, (+)-4/(−)-4, and (+)-5/(−)-5 were identified as three enantiomeric pairs. The planar structures and absolute configurations of 18 were determined through high-resolution electrospray ionization mass spectrometry (HR-ESI-MS), 1D & 2D nuclear magnetic resonance (NMR) spectroscopy, electronic circular dichroism (ECD) calculations, and X-ray diffraction crystallography. A cholesterol 7α-hydroxylase (Cyp7a1) luciferase reporter assay revealed significant anti-cholestatic activities for compounds 1, (+)-4, 6, 7, 1214, and 16. Additionally, compound 6 demonstrated anti-cholestatic effects through the farnesoid X receptor (FXR)-associated signaling pathways in vitro and in vivo. These findings suggest potential applications for I. Lophanthoides in pharmaceutical development.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return